WO2006004577A3 - Lubricant for the ocular surface - Google Patents
Lubricant for the ocular surface Download PDFInfo
- Publication number
- WO2006004577A3 WO2006004577A3 PCT/US2005/006737 US2005006737W WO2006004577A3 WO 2006004577 A3 WO2006004577 A3 WO 2006004577A3 US 2005006737 W US2005006737 W US 2005006737W WO 2006004577 A3 WO2006004577 A3 WO 2006004577A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- eyedrop
- well
- lubricant
- ocular surface
- jojoba wax
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002559503A CA2559503A1 (en) | 2004-03-12 | 2005-03-01 | Lubricant for the ocular surface |
JP2007502857A JP2007528897A (en) | 2004-03-12 | 2005-03-01 | Lubricant for ocular surface |
AU2005260090A AU2005260090B2 (en) | 2004-03-12 | 2005-03-01 | Lubricant for the ocular surface |
EP05794290A EP1727565A2 (en) | 2004-03-12 | 2005-03-01 | Lubricant for the ocular surface |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55247704P | 2004-03-12 | 2004-03-12 | |
US60/552,477 | 2004-03-12 | ||
US56268304P | 2004-04-15 | 2004-04-15 | |
US60/562,683 | 2004-04-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006004577A2 WO2006004577A2 (en) | 2006-01-12 |
WO2006004577A3 true WO2006004577A3 (en) | 2006-07-20 |
Family
ID=35311617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/006737 WO2006004577A2 (en) | 2004-03-12 | 2005-03-01 | Lubricant for the ocular surface |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1727565A2 (en) |
JP (1) | JP2007528897A (en) |
AU (1) | AU2005260090B2 (en) |
CA (1) | CA2559503A1 (en) |
WO (1) | WO2006004577A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2451452A (en) * | 2007-07-30 | 2009-02-04 | Donald Henry Yates | A lubricant formulation |
US20130023575A1 (en) * | 2011-07-22 | 2013-01-24 | Kamran Hosseini | Compositions and methods for the treatment of ocular surface allergies |
ITFI20120044A1 (en) * | 2012-03-01 | 2013-09-02 | Biodue Spa | FORMULATION FOR OPHTHALMIC USE INCLUDING JOJOBA OIL. |
JP5989365B2 (en) * | 2012-03-19 | 2016-09-07 | ロート製薬株式会社 | Contact lens ophthalmic composition |
WO2014035450A1 (en) * | 2012-08-31 | 2014-03-06 | Bausch & Lomb Incorporated | Ophthalmic compositions with omega-3 fatty acids |
ES2641169T3 (en) * | 2013-01-24 | 2017-11-08 | Bausch & Lomb Incorporated | Poly (nitrogen / amine) derivatives of a natural wax or an alkoxylated derivative thereof and ophthalmic compositions |
JP6497812B2 (en) * | 2013-06-28 | 2019-04-10 | 学校法人慶應義塾 | Meibomian gland dysfunction treatment |
EP3261620B1 (en) * | 2015-02-24 | 2022-11-09 | The Board of Trustees of the University of Illinois | Methods and compositions for treating dry eye disease and other eye disorders |
CN105749360B (en) * | 2016-03-28 | 2019-06-18 | 赛克赛斯生物科技股份有限公司 | A kind of composition and the preparation method and application thereof for protecting cornea |
CA3032695C (en) | 2016-08-19 | 2021-11-23 | Akrivista, LLC | Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye |
WO2018212846A1 (en) | 2017-05-19 | 2018-11-22 | Ocugen, Inc. | Ophthalmic compositions and methods of use |
BR112020003276A2 (en) | 2017-08-18 | 2020-09-01 | Akrivista, LLC | methods of diagnosis and treatment of dry eye syndrome and compositions for treating a human eye |
WO2020123362A1 (en) * | 2018-12-10 | 2020-06-18 | EternaTear, Inc. | Ophthalmic formulations providing durable ocular lubrication |
KR102221500B1 (en) * | 2019-06-10 | 2021-03-04 | 인제대학교 산학협력단 | Method for manufacturing contact lens comprising beta-carotene for blocking blue lights |
US11471475B1 (en) | 2022-03-08 | 2022-10-18 | Ralph P. Stone | Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery |
US11679078B1 (en) | 2022-03-08 | 2023-06-20 | EternaTear, Inc. | Ophthalmic formulations and related methods |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0535545A1 (en) * | 1991-10-02 | 1993-04-07 | Ocular Research Of Boston Inc. | Artificial tears containing oil and wax |
EP0875244A2 (en) * | 1997-05-02 | 1998-11-04 | Ciba SC Holding AG | Cosmetically accceptable microstructured compositions |
WO2002051379A2 (en) * | 2000-12-23 | 2002-07-04 | Impetus Ag | Thixotropic nasal spray |
US20030008022A1 (en) * | 2001-07-07 | 2003-01-09 | Mogy Nabil Sadek El | Medical effect of jojoba oil |
WO2003049674A2 (en) * | 2001-11-07 | 2003-06-19 | Purcell Jojoba International, Inc. | Method for treatment of enveloped viruses using jojoba oil esters |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2495187A1 (en) * | 1980-12-02 | 1982-06-04 | Siderurgie Fse Inst Rech | PROCESS FOR PRODUCING METALLURGICAL CONTAINER FUND |
-
2005
- 2005-03-01 WO PCT/US2005/006737 patent/WO2006004577A2/en active Application Filing
- 2005-03-01 AU AU2005260090A patent/AU2005260090B2/en not_active Ceased
- 2005-03-01 JP JP2007502857A patent/JP2007528897A/en not_active Withdrawn
- 2005-03-01 CA CA002559503A patent/CA2559503A1/en not_active Abandoned
- 2005-03-01 EP EP05794290A patent/EP1727565A2/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0535545A1 (en) * | 1991-10-02 | 1993-04-07 | Ocular Research Of Boston Inc. | Artificial tears containing oil and wax |
EP0875244A2 (en) * | 1997-05-02 | 1998-11-04 | Ciba SC Holding AG | Cosmetically accceptable microstructured compositions |
WO2002051379A2 (en) * | 2000-12-23 | 2002-07-04 | Impetus Ag | Thixotropic nasal spray |
US20030008022A1 (en) * | 2001-07-07 | 2003-01-09 | Mogy Nabil Sadek El | Medical effect of jojoba oil |
WO2003049674A2 (en) * | 2001-11-07 | 2003-06-19 | Purcell Jojoba International, Inc. | Method for treatment of enveloped viruses using jojoba oil esters |
Also Published As
Publication number | Publication date |
---|---|
AU2005260090B2 (en) | 2008-06-05 |
AU2005260090A1 (en) | 2006-01-12 |
JP2007528897A (en) | 2007-10-18 |
EP1727565A2 (en) | 2006-12-06 |
CA2559503A1 (en) | 2006-01-12 |
WO2006004577A2 (en) | 2006-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006004577A3 (en) | Lubricant for the ocular surface | |
WO2011053801A3 (en) | Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye | |
WO2006071548A3 (en) | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases | |
WO2005002520A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
WO2006020859A3 (en) | Vision enhancing ophthalmic devices and related methods and compositions | |
BRPI0413381A (en) | compositions for releasing therapeutic compounds into the eyes and processes for the manufacture and use thereof | |
MXPA03008401A (en) | Combination of brimonidine and timolol for topical ophthalmic use. | |
WO2008029276A8 (en) | Compositions and methods for the treatment of ophthalmic disease | |
WO2005084635A3 (en) | Pharmaceutical ocular preparations suitable for the treatment of the ocular surface and related disorders/diseases | |
WO2007067495A3 (en) | Levodopa prodrug mesylate, compositions thereof, and uses thereof | |
WO2006055454A3 (en) | Ophthalmic compositions and methods for treating eyes | |
WO2007076360A8 (en) | (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions | |
WO2008140052A1 (en) | Prophylactic or therapeutic agent for posterior ocular disease comprising ropinirole or salt thereof as active ingredient | |
WO2006116591A3 (en) | Ophthalmic formulations comprising prednisolone acetate and tobramycin and uses thereof | |
WO2008131282A3 (en) | Biomechanical design of intracorneal inlays | |
WO2006002366A3 (en) | Biodegradable ocular devices, methods and systems | |
MX2007002824A (en) | Combined epithelial delaminator and inserter. | |
WO2007089584A3 (en) | Compositions and their uses directed to huntingtin | |
WO2010083173A3 (en) | Hydrophobic pseudo-endothelial implants for treating corneal edema | |
WO2007108968A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
MX2009012645A (en) | Formulations and methods for treating dry eye. | |
WO2006060363A3 (en) | Aspheric lenticule for keratophakia | |
WO2006044425A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
WO2007126364A8 (en) | Use of antisecretory factors for treating intraocular hypertension | |
MX2008015976A (en) | Topical treatment for diseases of eye surface. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 549759 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006/07607 Country of ref document: ZA Ref document number: 2007502857 Country of ref document: JP Ref document number: 2559503 Country of ref document: CA Ref document number: 200607607 Country of ref document: ZA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 5335/DELNP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005260090 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005794290 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2005260090 Country of ref document: AU Date of ref document: 20050301 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005260090 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005794290 Country of ref document: EP |